<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37515140</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>27</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Clinical and Biomarker Profile Responses to Rehabilitation Treatment in Patients with Long COVID Characterized by Chronic Fatigue.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1452</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v15071452</ELocationID><Abstract><AbstractText>Long COVID (LC) syndrome is a complex multiorgan symptom that persists beyond &gt;12 weeks after SARS-CoV-2 infection. The most frequently associated symptom is fatigue. Physical activity and exercise are recommended, although specific studies are lacking. The objectives of the present work are to analyze the impact of a supervised exercise program on the clinical evolution of LC with fatigue patients and to identify whether certain circulating biomarkers could predict the response to rehabilitation. The rehabilitation treatment response was analyzed in 14 women diagnosed with LC and fatigue, based on the changes in the 6 min walk test and Borg/Fatigue Impact scales. Patients who showed improvement in the meters walked were considered "responders" to the therapy. A total of 65% of patients responded to the exercise program, with an improvement in the meters walked and in oxygen saturation, with stability in the percentage of meters walked. Participants with obesity and those double-vaccinated against SARS-CoV-2 presented a lower degree of fatigue. LC patients presented a favorable response to a supervised exercise program. Differences in creatinine and protein levels were observed between rehabilitation therapy "responders" and "nonresponders". A good state of protein nutrition was related to a better rehabilitation response. The results are promising regarding possible predictive biomarkers of rehabilitation response, such as creatinine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Binetti</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>GEMMAIR Research Group, Department of Medicine and Surgery, Pere Virgili Institute for Health Research (IISPV), Rovira i Virgili University (URV), 43007 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine Unit, Joan XXIII University Hospital of Tarragona, 43007 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Real</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine Unit, Joan XXIII University Hospital of Tarragona, 43007 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renzulli</LastName><ForeName>Marcela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rehabilitation Unit, Joan XXIII University Hospital of Tarragona, 43007 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertran</LastName><ForeName>Laia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9052-1368</Identifier><AffiliationInfo><Affiliation>GEMMAIR Research Group, Department of Medicine and Surgery, Pere Virgili Institute for Health Research (IISPV), Rovira i Virgili University (URV), 43007 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riesco</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>GEMMAIR Research Group, Department of Medicine and Surgery, Pere Virgili Institute for Health Research (IISPV), Rovira i Virgili University (URV), 43007 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine Unit, Joan XXIII University Hospital of Tarragona, 43007 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perpi&#xf1;an</LastName><ForeName>Carles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Catalan Institute for Health (ICS), 43202 Reus, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohedano</LastName><ForeName>Alba</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0005-0732-6868</Identifier><AffiliationInfo><Affiliation>Internal Medicine Unit, Joan XXIII University Hospital of Tarragona, 43007 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segundo</LastName><ForeName>Rosa San</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Rehabilitation Unit, Joan XXIII University Hospital of Tarragona, 43007 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurobehavioral and Health Research Group (NEUROLAB), Rovira i Virgili University (URV), 43007 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortiz</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rehabilitation Unit, Joan XXIII University Hospital of Tarragona, 43007 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porras</LastName><ForeName>Jos&#xe9; Antonio</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>GEMMAIR Research Group, Department of Medicine and Surgery, Pere Virgili Institute for Health Research (IISPV), Rovira i Virgili University (URV), 43007 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine Unit, Joan XXIII University Hospital of Tarragona, 43007 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pineda</LastName><ForeName>Daniela Rosanna</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Rehabilitation Unit, Joan XXIII University Hospital of Tarragona, 43007 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Auguet</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0396-6428</Identifier><AffiliationInfo><Affiliation>GEMMAIR Research Group, Department of Medicine and Surgery, Pere Virgili Institute for Health Research (IISPV), Rovira i Virgili University (URV), 43007 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine Unit, Joan XXIII University Hospital of Tarragona, 43007 Tarragona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">chronic fatigue</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">physical rehabilitation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37515140</ArticleId><ArticleId IdType="pmc">PMC10384083</ArticleId><ArticleId IdType="doi">10.3390/v15071452</ArticleId><ArticleId IdType="pii">v15071452</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher A., Balfanz P., Cornelissen C., M&#xfc;ller A., Bergs I., Marx N., M&#xfc;ller-Wieland D., Hartmann B., Dreher M., M&#xfc;ller T. Follow up of Patients with Severe Coronavirus Disease 2019 (COVID-19): Pulmonary and Extrapulmonary Disease Sequelae. Respir. Med. 2020;174:106197. doi: 10.1016/j.rmed.2020.106197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106197</ArticleId><ArticleId IdType="pmc">PMC7573668</ArticleId><ArticleId IdType="pubmed">33120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and Predictors of Long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E., Teb&#xe9; C., Fernandez-Bertolin S., Aragon M., Recalde M., Roel E., Prats-Uribe A., Prieto-Alhambra D., Duarte-Salles T. The Natural History of Symptomatic COVID-19 during the First Wave in Catalonia. Nat. Commun. 2021;12:777. doi: 10.1038/s41467-021-21100-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21100-y</ArticleId><ArticleId IdType="pmc">PMC7858639</ArticleId><ArticleId IdType="pubmed">33536436</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco J.V.A., Garegnani L.I., Oltra G.V., Metzendorf M.-I., Trivisonno L.F., Sgarbossa N., Ducks D., Heldt K., Mumm R., Barnes B., et al. Long-Term Health Symptoms and Sequelae Following SARS-CoV-2 Infection: An Evidence Map. Int. J. Environ. Res. Public Health. 2022;19:9915. doi: 10.3390/ijerph19169915.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19169915</ArticleId><ArticleId IdType="pmc">PMC9408764</ArticleId><ArticleId IdType="pubmed">36011562</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of Post-Acute Covid-19 in Primary Care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post-Acute Sequelae of COVID-19 (PASC) or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Gonz&#xe1;lez A., Ara&#xfa;jo-Ameijeiras A., Fern&#xe1;ndez-Villar A., Crespo M., Poveda E., The Cohort COVID-19 of the Galicia Sur Health Research Institute. Cabrera J.J., del Campo V., de Araujo B.G., G&#xf3;mez C., et al. Long COVID in Hospitalized and Non-Hospitalized Patients in a Large Cohort in Northwest Spain, a Prospective Cohort Study. Sci. Rep. 2022;12:3369. doi: 10.1038/s41598-022-07414-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07414-x</ArticleId><ArticleId IdType="pmc">PMC8888560</ArticleId><ArticleId IdType="pubmed">35233035</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A Clinical Case Definition of Post-COVID-19 Condition by a Delphi Consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-Acute COVID-19 Syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major Findings, Mechanisms and Recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottschalk C.G., Peterson D., Armstrong J., Knox K., Roy A. Potential Molecular Mechanisms of Chronic Fatigue in Long Haul COVID and Other Viral Diseases. Infect. Agent. Cancer. 2023;18:7. doi: 10.1186/s13027-023-00485-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13027-023-00485-z</ArticleId><ArticleId IdType="pmc">PMC9902840</ArticleId><ArticleId IdType="pubmed">36750846</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J., Laurence J. Long COVID Endotheliopathy: Hypothesized Mechanisms and Potential Therapeutic Approaches. J. Clin. Investig. 2022;132:e161167. doi: 10.1172/JCI161167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalamaga M. Obesity, Insulin Resistance, Adipocytokines and Breast Cancer: New Biomarkers and Attractive Therapeutic Targets. World J. Exp. Med. 2013;3:34. doi: 10.5493/wjem.v3.i3.34.</Citation><ArticleIdList><ArticleId IdType="doi">10.5493/wjem.v3.i3.34</ArticleId><ArticleId IdType="pmc">PMC3905595</ArticleId><ArticleId IdType="pubmed">24520544</ArticleId></ArticleIdList></Reference><Reference><Citation>Brito-Zer&#xf3;n P., Melchor S., Seror R., Priori R., Solans R., Kostov B., Baldini C., Carubbi F., Callejas J.L., Guisado-Vasco P., et al. SARS-CoV-2 Infection in Patients with Primary Sj&#xf6;gren Syndrome: Characterization and Outcomes of 51 Patients. Rheumatology. 2021;60:2946&#x2013;2957. doi: 10.1093/rheumatology/keaa748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa748</ArticleId><ArticleId IdType="pmc">PMC7798705</ArticleId><ArticleId IdType="pubmed">33316070</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Billig Rose E., Lindsell C.J., Shapiro N.I., Files D.C., Gibbs K.W., Prekker M.E., Steingrub J.S., Smithline H.A., Gong M.N., et al. Characteristics of Adult Outpatients and Inpatients with COVID-19&#x2014;11 Academic Medical Centers, United States, March&#x2013;May 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:841&#x2013;846. doi: 10.15585/mmwr.mm6926e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6926e3</ArticleId><ArticleId IdType="pmc">PMC7332092</ArticleId><ArticleId IdType="pubmed">32614810</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. For the Gemelli Against COVID-19 Post-Acute Care Study Group Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S., Heightman M., Hillman T.E., Jacob J., Jarvis H.C., et al. &#x2018;Long-COVID&#x2019;: A Cross-Sectional Study of Persisting Symptoms, Biomarker and Imaging Abnormalities Following Hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M., Maralakunte M., Garg S., Dhooria S., Sehgal I., Bhalla A.S., Vijayvergiya R., Grover S., Bhatia V., Jagia P., et al. The Conundrum of &#x2018;Long-COVID-19&#x2b9;: A Narrative Review. Int. J. Gen. Med. 2021;14:2491&#x2013;2506. doi: 10.2147/IJGM.S316708.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S316708</ArticleId><ArticleId IdType="pmc">PMC8214209</ArticleId><ArticleId IdType="pubmed">34163217</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake K.A., Talantov D., Tong G.J., Lin J.T., Verheijden S., Katz S., Leung J.M., Yuen B., Krishna V., Wu M.J., et al. Multi-Omic Profiling Reveals Early Immunological Indicators for Identifying COVID-19 Progressors. bioRxiv. 2023 doi: 10.1101/2023.05.25.542297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.05.25.542297</ArticleId><ArticleId IdType="pubmed">37852344</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, Complications and Management of Long COVID: A Review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez Sol&#xe0; J. El s&#xed;ndrome de fatiga cr&#xf3;nica. Med. Integral. 2002;40:56&#x2013;63.</Citation></Reference><Reference><Citation>Agostini F., Mangone M., Ruiu P., Paolucci T., Santilli V., Bernetti A. Rehabilitation Setting during and after Covid-19: An Overview on Recommendations. J. Rehabil. Med. 2021;53:jrm00141. doi: 10.2340/16501977-2776.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2776</ArticleId><ArticleId IdType="pmc">PMC8772378</ArticleId><ArticleId IdType="pubmed">33284353</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull F.C., Al-Ansari S.S., Biddle S., Borodulin K., Buman M.P., Cardon G., Carty C., Chaput J.-P., Chastin S., Chou R., et al. World Health Organization 2020 Guidelines on Physical Activity and Sedentary Behaviour. Br. J. Sports Med. 2020;54:1451&#x2013;1462. doi: 10.1136/bjsports-2020-102955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2020-102955</ArticleId><ArticleId IdType="pmc">PMC7719906</ArticleId><ArticleId IdType="pubmed">33239350</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilar-Navarro S.G., Mimenza-Alvarado A.J., Palacios-Garc&#xed;a A.A., Samudio-Cruz A., Guti&#xe9;rrez-Guti&#xe9;rrez L.A., &#xc1;vila-Funes J.A. Validez y confiabilidad del MoCA (Montreal Cognitive Assessment) para el tamizaje del deterioro cognoscitivo en m&#xe9;xico. Rev. Colomb. Psiquiatr. 2018;47:237&#x2013;243. doi: 10.1016/j.rcp.2017.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rcp.2017.05.003</ArticleId><ArticleId IdType="pubmed">30286846</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova C., Celli B.R., Barria P., Casas A., Cote C., de Torres J.P., Jardim J., Lopez M.V., Marin J.M., Montes de Oca M., et al. The 6-Min Walk Distance in Healthy Subjects: Reference Standards from Seven Countries. Eur. Respir. J. 2011;37:150&#x2013;156. doi: 10.1183/09031936.00194909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00194909</ArticleId><ArticleId IdType="pubmed">20525717</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattadori G., Di Marco S., Baravelli M., Picozzi A., Ambrosio G. Exercise Training in Post-COVID-19 Patients: The Need for a Multifactorial Protocol for a Multifactorial Pathophysiology. J. Clin. Med. 2022;11:2228. doi: 10.3390/jcm11082228.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11082228</ArticleId><ArticleId IdType="pmc">PMC9028177</ArticleId><ArticleId IdType="pubmed">35456321</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., De Oliveira M.H.S., Peligro P.J., Velasco J.V., Macaranas I., Ver A.T., Pangilinan F.C., Pastrana A., Goldrich N., Kavteladze D., et al. Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022;11:7314. doi: 10.3390/jcm11247314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Notarte K.I., Peligro P.J., Velasco J.V., Ocampo M.J., Henry B.M., Arendt-Nielsen L., Torres-Macho J., Plaza-Manzano G. Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature. Viruses. 2022;14:2629. doi: 10.3390/v14122629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponti G., Maccaferri M., Ruini C., Tomasi A., Ozben T. Biomarkers Associated with COVID-19 Disease Progression. Crit. Rev. Clin. Lab. Sci. 2020;57:389&#x2013;399. doi: 10.1080/10408363.2020.1770685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2020.1770685</ArticleId><ArticleId IdType="pmc">PMC7284147</ArticleId><ArticleId IdType="pubmed">32503382</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry B.M., de Oliveira M.H.S., Benoit S., Plebani M., Lippi G. Hematologic, Biochemical and Immune Biomarker Abnormalities Associated with Severe Illness and Mortality in Coronavirus Disease 2019 (COVID-19): A Meta-Analysis. Clin. Chem. Lab. Med. CCLM. 2020;58:1021&#x2013;1028. doi: 10.1515/cclm-2020-0369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-0369</ArticleId><ArticleId IdType="pubmed">32286245</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or Post-COVID-19 Syndrome: Putative Pathophysiology, Risk Factors, and Treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent Clotting Protein Pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Is Accompanied by Increased Levels of Antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopp S., Moik F., Klok F.A., Gattinger D., Petrovic M., Vonbank K., Koczulla A.R., Ay C., Zwick R.H. Outpatient Pulmonary Rehabilitation in Patients with Long COVID Improves Exercise Capacity, Functional Status, Dyspnea, Fatigue, and Quality of Life. Respiration. 2022;101:593&#x2013;601. doi: 10.1159/000522118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522118</ArticleId><ArticleId IdType="pmc">PMC9059007</ArticleId><ArticleId IdType="pubmed">35203084</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Xia W., Zhan C., Liu S., Yin Z., Wang J., Chong Y., Zheng C., Fang X., Cheng W., et al. A Telerehabilitation Programme in Post-Discharge COVID-19 Patients (TERECO): A Randomised Controlled Trial. Thorax. 2022;77:697&#x2013;706. doi: 10.1136/thoraxjnl-2021-217382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217382</ArticleId><ArticleId IdType="pmc">PMC8318721</ArticleId><ArticleId IdType="pubmed">34312316</ArticleId></ArticleIdList></Reference><Reference><Citation>Brugliera L., Spina A., Castellazzi P., Cimino P., Arcuri P., Deriu M., Zanetta C., Angelone S., Capitanio J., Alemanno F., et al. Rehabilitative of COVID-19 Patients with Acute Lower Extremity Ischemia and Amputation. J. Rehabil. Med. 2020;52:1&#x2013;4. doi: 10.2340/16501977-2714.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2714</ArticleId><ArticleId IdType="pubmed">32720698</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandberg J., Olsson M., Ekstr&#xf6;m M. Underlying Conditions Contributing to Breathlessness in the Population. Curr. Opin. Support. Palliat. Care. 2021;15:219&#x2013;225. doi: 10.1097/SPC.0000000000000568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SPC.0000000000000568</ArticleId><ArticleId IdType="pmc">PMC8631149</ArticleId><ArticleId IdType="pubmed">34610625</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 Vaccination on the Risk of Developing Long-COVID and on Existing Long-COVID Symptoms: A Systematic Review. eClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou H.C., Pavli A., Tsakris A. Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines. 2021;9:497. doi: 10.3390/vaccines9050497.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9050497</ArticleId><ArticleId IdType="pmc">PMC8151752</ArticleId><ArticleId IdType="pubmed">34066007</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith-Ryan A.E., Hirsch K.R., Saylor H.E., Gould L.M., Blue M.N.M. Nutritional Considerations and Strategies to Facilitate Injury Recovery and Rehabilitation. J. Athl. Train. 2020;55:918&#x2013;930. doi: 10.4085/1062-6050-550-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.4085/1062-6050-550-19</ArticleId><ArticleId IdType="pmc">PMC7534941</ArticleId><ArticleId IdType="pubmed">32991705</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Yang H., Wang J., Li X., Xue C., Niu C., Liao P. Serum Albumin Levels Are a Predictor of COVID-19 Patient Prognosis: Evidence from a Single Cohort in Chongqing, China. Int. J. Gen. Med. 2021;14:2785&#x2013;2797. doi: 10.2147/IJGM.S312521.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S312521</ArticleId><ArticleId IdType="pmc">PMC8238547</ArticleId><ArticleId IdType="pubmed">34194238</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulloque-Badaracco J.R., Mosquera-Rojas M.D., Hernandez-Bustamante E.A., Alarc&#xf3;n-Braga E.A., Herrera-A&#xf1;azco P., Benites-Zapata V.A. Prognostic Value of Albumin-to-Globulin Ratio in COVID-19 Patients: A Systematic Review and Meta-Analysis. Heliyon. 2022;8:e09457. doi: 10.1016/j.heliyon.2022.e09457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2022.e09457</ArticleId><ArticleId IdType="pmc">PMC9113764</ArticleId><ArticleId IdType="pubmed">35601226</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson J.L., Senger R.S., Talty J., Du P., Sayed-Issa A., Avellar M.L., Ngo L.T., Gomez De La Espriella M., Fazili T.N., Jackson-Akers J.Y., et al. Alterations in the Molecular Composition of COVID-19 Patient Urine, Detected Using Raman Spectroscopic/Computational Analysis. PLoS ONE. 2022;17:e0270914. doi: 10.1371/journal.pone.0270914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0270914</ArticleId><ArticleId IdType="pmc">PMC9292080</ArticleId><ArticleId IdType="pubmed">35849572</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova J.-L., Abel L. Mechanisms of Viral Inflammation and Disease in Humans. Science. 2021;374:1080&#x2013;1086. doi: 10.1126/science.abj7965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj7965</ArticleId><ArticleId IdType="pmc">PMC8697421</ArticleId><ArticleId IdType="pubmed">34822298</ArticleId></ArticleIdList></Reference><Reference><Citation>Getts D.R., Chastain E.M.L., Terry R.L., Miller S.D. Virus Infection, Antiviral Immunity, and Autoimmunity. Immunol. Rev. 2013;255:197&#x2013;209. doi: 10.1111/imr.12091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12091</ArticleId><ArticleId IdType="pmc">PMC3971377</ArticleId><ArticleId IdType="pubmed">23947356</ArticleId></ArticleIdList></Reference><Reference><Citation>Ian R.M., Noel R. Rose the Autoimmune Diseases. 5th ed. Elsevier; Amsterdam, The Netherlands: 2014.</Citation></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological Dysfunction Persists for 8 Months Following Initial Mild-to-Moderate SARS-CoV-2 Infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A., Vlok M., Turner S., Venter C., Laubscher G.J., Kell D.B., Pretorius E. Proteomics of Fibrin Amyloid Microclots in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Shows Many Entrapped pro-Inflammatory Molecules That May Also Contribute to a Failed Fibrinolytic System. Cardiovasc. Diabetol. 2022;21:190. doi: 10.1186/s12933-022-01623-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01623-4</ArticleId><ArticleId IdType="pmc">PMC9491257</ArticleId><ArticleId IdType="pubmed">36131342</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira C.R., Jason L.A., Unutmaz D., Bateman L., Vernon S.D. Improvement of Long COVID Symptoms over One Year. Front. Med. 2023;9:1065620. doi: 10.3389/fmed.2022.1065620.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1065620</ArticleId><ArticleId IdType="pmc">PMC9868805</ArticleId><ArticleId IdType="pubmed">36698810</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>